| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.25 | 8e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 6e-06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 9e-06 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0007 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0008 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |